Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparator Study of 68Ga-DOTATOC PET/CT With Octreoscan + High-resolution, Contrast-enhanced CT for Diagnosis and Staging in Neuroendocrine Tumors and Other Somatostatin Receptor Positive Tumors

NCT01869725 is registered in ClinicalTrials.gov with Sue O'Dorisio as lead sponsor.

NCT NCT01869725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01869725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparator Study of 68Ga-DOTATOC PET/CT With Octreoscan + High-resolution, Contrast-enhanced CT for Diagnosis and Staging in Neuroendocrine Tumors and Other Somatostatin Receptor Positive Tumors
Lead sponsor
Sue O'Dorisio
Phase
Phase 2
Overall status
Completed
Start date
April 1, 2013
Completion date
December 26, 2018
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult medulloblastoma, childhood medulloblastoma, neuroblastoma, neuroendocrine tumor, somatostatinoma